Metachronous lung cancer: The role of improved postoperative surveillance

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 3, 2004, Pages 633-635

  Scott, Walter J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HUMAN; LUNG CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL MORTALITY;

EID: 1542344325     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.11.052     Document Type: Editorial

References (18)

1. Battafarano RJ, Force SD, Meyers BF, et al. Benefits of resection for metachronous lung cancer. J Thorac Cardiovasc Surg. 2004;127:836-42.
2. Martini N, Melamed MR. Multiple primary lung cancers: survival after resection of metachronous non-small cell lung cancer in 127 patients. J Thorac Cardiovasc Surg. 1975;70:606-12.
3. van Rens MT, Zanen P, de la Riviere AB, Elbers HRJ, van Swieten HA, van den Bosch JMM. Ann Thorac Surg. 2001;71:309-13.
4. Rea F, Zuin A, Callegaro D, Bortolottti L, Guanella G, Sartori F. Surgical results for multiple primary lung cancers. Eur J Cardiothorac Surg. 2001;20:489-95.
5. Aziz TM, Saad RA, Glasser J, Jilaihawi AN, Prakash D. The management of second primary lung cancers. A single centre experience in 15 years. Eur J Cardiothorac Surg. 2002;21:527-33.
6. Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1990;99:769-78.
7. Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg. 1995;59:863-7.
8. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120-9.
9. Mathisen DJ, Jensik RJ, Faber LP, Kittle FC. Survival following resection for second and third primary lung cancers. J Thorac Cardiovasc Surg. 1984;88:502-10.
10. Lippman SM, Lee JJ, Karp DD, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst. 2001;93:605-18.
11. Ichinose Y, Hara N, Ohta M, Kuda T, Asoh H, Chikama H. DNA ploidy patterns of tumors diagnosed as metachronous or recurrent lung cancer. Ann Thorac Surg. 1991;52:469-73.
12. Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1998;90:972-7.
13. Rice D, Kim H, Sabichi A, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg, 2003;76:1001-8.
14. Chiu C-H, Chem M-S, Wu M-H, et al. Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: preliminary report. J Thorac Cardiovasc Surg. 2003;125:1300-5.
15. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet. 1999;354:99-105.
16. Swensen SJ. CT screening for lung cancer. AJR Am J Roentgenol. 2002;179:833-6.
17. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer. Surgery. 2003;134:691-7.
18. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for TI NO non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615-22.